23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Tectonic Therapeutic, Inc. › 2025-2026

Tectonic Therapeutic, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Tectonic Therapeutic, Inc.’s Form 8-K, filed June 10, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 4Ballot items
  • 134Asset managers, any item
  • 606Fund votes
  • June 8, 2026Meeting date

Results at a glance

Meeting of June 8, 2026: 4 items on Tectonic Therapeutic, Inc.’s Form 8-K, filed June 10, 2026: 2 approved · 2 passed (calculated).

Dissent

Significant dissent: 1 director (20.5% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Tectonic Therapeutic, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Tectonic Therapeutic, Inc.

These tallies are Tectonic Therapeutic, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Tectonic Therapeutic, Inc. — official shareholder meeting results, meeting held June 8, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Timothy A. Springer 11,461,485---- 2,963,7502,806,066 79%Passed (calculated)—
Elect Director: Stefan Vitorovic 13,937,996---- 487,2392,806,066 97%Passed (calculated)—
2. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm 17,225,9483,8311,522 --0 99.9%Approved—
3. Advisory Approval on Executive Compensation 14,292,497118,27114,467 --2,806,066 99.2%Approved—

Source: Tectonic Therapeutic, Inc., Form 8-K, filed with the SEC on June 10, 2026 — read the filing on EDGAR.

How asset managers voted at the Tectonic Therapeutic, Inc. 2025-2026 meeting

134 asset managers disclosed a vote on at least one Tectonic Therapeutic, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Stefan Vitorovic

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 13,937,996WITHHELD: 487,239
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of Directors: Stefan Vitorovic, M.S., M.B.A.

Tectonic Therapeutic, Inc.’s own tally for this item (“Elect Director: Stefan Vitorovic”): 13,937,996 for, 487,239 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 1,298,533 for, 167 withheld.

FOR
FOR: 1,298,533WITHHOLD: 167
Largest asset managers voting on “Election of Directors: Stefan Vitorovic, M.S., M.B.A.” at Tectonic Therapeutic, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity820,8400 00For
BlackRock139,8830 00For
Columbia Threadneedle130,5840 00For
Vanguard57,7460 044For
T. Rowe Price32,7280 00For
Northern Trust16,1080 00For
Lincoln Financial11,0940 00For
Charles Schwab10,8370 00For
ALPS ETF Trust10,3560 00For
Equitable8,2210 00For
MUTUAL FUND SERIES TRUST6,8490 00For
ETFis Series Trust I5,7590 00For
Global X5,2710 00For
JPMorgan4,8650 00For
Bridge Builder Trust4,7160 00For
Pacific Life4,2170 00For
Voya3,9500 00For
Brighthouse3,6080 00For
FORUM FUNDS II3,5070 00For
American Century3,2240 00For
ProShares2,2590 00For
AIG/SunAmerica1,9900 00For
QUANTITATIVE MASTER SERIES LLC1,5000 00For
SEI1,3000 00For
Calvert1,1220 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Timothy A. Springer

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD
FOR: 11,461,485WITHHELD: 2,963,750
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of Directors: Timothy A. Springer, Ph.D.

Tectonic Therapeutic, Inc.’s own tally for this item (“Elect Director: Timothy A. Springer”): 11,461,485 for, 2,963,750 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 237,562 for, 1,061,138 withheld.

FORWITHHOLD
FOR: 237,562WITHHOLD: 1,061,138
Largest asset managers voting on “Election of Directors: Timothy A. Springer, Ph.D.” at Tectonic Therapeutic, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity7,0260 0813,814Withhold
BlackRock00 0139,883Withhold
Columbia Threadneedle130,5840 00For
Vanguard57,7250 065For
T. Rowe Price00 032,728Withhold
Northern Trust00 016,108Withhold
Lincoln Financial11,0940 00For
Charles Schwab10,8370 00For
ALPS ETF Trust00 010,356Withhold
Equitable00 08,221Withhold
MUTUAL FUND SERIES TRUST00 06,849Withhold
ETFis Series Trust I00 05,759Withhold
Global X5,2710 00For
JPMorgan4,8650 00For
Bridge Builder Trust00 04,716Withhold
Pacific Life00 04,217Withhold
Voya00 03,950Withhold
Brighthouse2,5100 01,098Mixed
FORUM FUNDS II3,5070 00For
American Century00 03,224Withhold
ProShares00 02,259Withhold
AIG/SunAmerica00 01,990Withhold
QUANTITATIVE MASTER SERIES LLC00 01,500Withhold
SEI1,3000 00For
Calvert00 01,122Withhold

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Advisory Approval on Executive Compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.2% Approved · of votes cast

FOR 99.2%
FOR: 14,292,497AGAINST: 118,271

Prior year: 99.5% for (June 6, 2025 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: ADVISORY APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

Tectonic Therapeutic, Inc.’s own tally for this item (“3. Advisory Approval on Executive Compensation”): 14,292,497 for, 118,271 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Advisory Approval on Executive Compensation The stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's Named Executive Officers, as disclosed in the Company's proxy statement for the 2026 Annual Meeting.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 40 asset managers voting on “ADVISORY APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at Tectonic Therapeutic, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity820,8400 00For
BlackRock139,8830 00For
Columbia Threadneedle130,5840 00For
Vanguard57,7900 00For
T. Rowe Price32,7280 00For
Northern Trust16,1080 00For
Lincoln Financial11,0940 00For
Charles Schwab10,8370 00For
ALPS ETF Trust10,3560 00For
Equitable4,7813,440 00Mixed
MUTUAL FUND SERIES TRUST6,8490 00For
ETFis Series Trust I5,7590 00For
Global X5,2710 00For
JPMorgan4,8650 00For
Bridge Builder Trust4,7160 00For
Pacific Life4,2170 00For
Voya3,9500 00For
Brighthouse3,6080 00For
FORUM FUNDS II3,5070 00For
American Century03,224 00Against
ProShares2,2590 00For
AIG/SunAmerica1,9900 00For
QUANTITATIVE MASTER SERIES LLC1,5000 00For
SEI1,3000 00For
Calvert01,122 00Against

Fund voting reports, all 40 managers: 1,290,904 for, 7,796 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 109 asset managers voting on “ADVISORY APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at Tectonic Therapeutic, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity1,927,3990 00For
Aberdeen1,141,8240 00For
First Light Asset Management, LLC622,2890 00For
5AM Venture Management, LLC606,6600 00For
BlackRock234,9454,708 00For
ORBIMED ADVISORS LLC226,6000 00For
KENNEDY CAPITAL MANAGEMENT LLC89,97759,172 00Mixed
BRAIDWELL LP147,4650 00For
Vestal Point Capital, LP140,0320 00For
State Street102,703355 00For
WELLS FARGO CLEARING SERVICES, LLC62,1370 00For
Connor, Clark & Lunn Investment Management Ltd.60,0010 00For
Northern Trust55,443498 00For
T. Rowe Price47,7260 00For
WELLS FARGO ADVISORS FINANCIAL NETWORK, LLC41,4000 00For
Tetragon Partners GP Ltd37,5880 00For
Aldebaran Capital, LLC37,0010 00For
MELLON INVESTMENTS Corp31,2620 00For
Soleus Capital Management, L.P.28,2680 00For
Vanguard24,2730 00For
SECTORAL ASSET MANAGEMENT INC24,0000 00For
Wellington21,2110 00For
Point7220,0490 00For
MONIMUS CAPITAL MANAGEMENT, LP00 11,1330Abstain
Charles Schwab10,9390 00For

Institutional-manager reports, all 109 managers: 5,860,808 for, 102,537 against, 11,133 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of Appointment of the Company's Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 17,225,948AGAINST: 3,831

Prior year: 100.0% for (June 6, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

Tectonic Therapeutic, Inc.’s own tally for this item (“2. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm”): 17,225,948 for, 3,831 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment by the Audit Committee of the Company's Board of Directors of Deloitte & Touche LLP as the Company's independent registered public accounting fi…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 1,298,700 for.

FOR
FOR: 1,298,700
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at Tectonic Therapeutic, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity820,8400 00For
BlackRock139,8830 00For
Columbia Threadneedle130,5840 00For
Vanguard57,7900 00For
T. Rowe Price32,7280 00For
Northern Trust16,1080 00For
Lincoln Financial11,0940 00For
Charles Schwab10,8370 00For
ALPS ETF Trust10,3560 00For
Equitable8,2210 00For
MUTUAL FUND SERIES TRUST6,8490 00For
ETFis Series Trust I5,7590 00For
Global X5,2710 00For
JPMorgan4,8650 00For
Bridge Builder Trust4,7160 00For
Pacific Life4,2170 00For
Voya3,9500 00For
Brighthouse3,6080 00For
FORUM FUNDS II3,5070 00For
American Century3,2240 00For
ProShares2,2590 00For
AIG/SunAmerica1,9900 00For
QUANTITATIVE MASTER SERIES LLC1,5000 00For
SEI1,3000 00For
Calvert1,1220 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Largest Tectonic Therapeutic, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 18,869,186 shares outstanding at the time of that meeting.

Fund voting reports: top Tectonic Therapeutic, Inc. shareholders by shares voted on “ADVISORY APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 4.35%
2BlackRock 0.74%
3Columbia Threadneedle 0.69%
4Vanguard 0.31%
5T. Rowe Price 0.17%
6Northern Trust 0.09%
7Lincoln Financial 0.06%
8Charles Schwab 0.06%
9ALPS ETF Trust 0.05%
10Equitable 0.04%
Institutional-manager reports: top Tectonic Therapeutic, Inc. shareholders by shares voted on “ADVISORY APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 10.21%
2Aberdeen 6.05%
3First Light Asset Management, LLC 3.30%
45AM Venture Management, LLC 3.22%
5BlackRock 1.27%
6ORBIMED ADVISORS LLC 1.20%
7KENNEDY CAPITAL MANAGEMENT LLC 0.79%
8BRAIDWELL LP 0.78%
9Vestal Point Capital, LP 0.74%
10State Street 0.55%

Reported Tectonic Therapeutic, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Tectonic Therapeutic, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
FMR (Fidelity)2,816,494 14.93%Form 13F, quarter ended March 31, 2026
Chen Yu1,169,760 6.20%Schedule 13G, filed February 27, 2026
Aberdeen Group plc1,141,824 6.05%Schedule 13G, filed January 29, 2026
BlackRock860,352 4.56%Form 13F, quarter ended March 31, 2026
Vanguard Group599,898 3.18%Form 13F, quarter ended March 31, 2026
Geode Capital268,273 1.42%Form 13F, quarter ended March 31, 2026
State Street213,505 1.13%Form 13F, quarter ended March 31, 2026
T. Rowe Price164,055 0.87%Form 13F, quarter ended March 31, 2026
D.E. Shaw116,120 0.62%Form 13F, quarter ended March 31, 2026
Morgan Stanley94,435 0.50%Form 13F, quarter ended March 31, 2026

Percentages above are of 18,869,186 shares outstanding, as reported by Tectonic Therapeutic, Inc. on its Form 10-Q dated May 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Tectonic Therapeutic, Inc.'s shareholder meeting held June 8, 2026, in the 2025-2026 proxy season, 134 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 606 separate fund positions. On the most widely held item on that ballot — ADVISORY APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. — Tectonic Therapeutic, Inc.'s filing reports the proposal as approved, with 99.2% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Tectonic Therapeutic, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Tectonic Therapeutic, Inc.’s 10-Q dated May 1, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Tectonic Therapeutic, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Tectonic Therapeutic (TECX) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/tectonic-therapeutic-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.